EXHIBIT 31.2

                  CERTIFICATION OF CFO PURSUANT TO SECTION 302
                        OF THE SARBANES-OXLEY ACT OF 2002

I, M. Dwight Cantrell, certify that:

1.   I have reviewed this annual report on Form 10-KSB of Endovasc, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a  material  fact  or  omit  to state a material fact necessary to make the
     statements  made, in light of the circumstances under which such statements
     were  made,  not  misleading  with  respect  to  the period covered by this
     report;

3.   Based  on  my  knowledge,  the  financial  statements,  and other financial
     information  included  in  this  report,  fairly  present  in  all material
     respects  the  financial condition, results of operations and cash flows of
     Endovasc,  Inc.  as  of,  and  for,  the  periods presented in this report;

4.   Endovasc, Inc.'s other certifying officer and I:

     a)   are  responsible  for establishing and maintaining disclosure controls
          and  procedures  (as  defined  in  Exchange  Act  rules  13a-15(e) and
          15d-15(e))  for  Endovasc,  Inc  and  have:

     b)   designed  such  disclosure  controls  and  procedures,  or caused such
          disclosure  controls  and  procedures  to  be  designed  under  our
          supervision, to ensure that material information relating to Endovasc,
          Inc.,  including its consolidated subsidiaries, is made known to us by
          others  within those entities, particularly during the period in which
          this  report  is  being  prepared;

     c)   evaluated  the  effectiveness  of Endovasc, Inc.'s disclosure controls
          and  procedures and presented in this report our conclusions about the
          effectiveness of the disclosure controls and procedures, as of the end
          of  the  period  covered  by this report based on such evaluation; and

     d)   Disclosed  in  this  report  any  change  in Endovasc, Inc.'s internal
          control over financial reporting that occurred during Endovasc, Inc.'s
          most recent fiscal year that has materially affected, or is reasonably
          likely  to  materially  affect, Endovasc, Inc.'s internal control over
          financial  reporting;  and

5.   Endovasc,  Inc.'s  other  certifying officer and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     Endovasc, Inc.'s auditors and the audit committee of Endovasc, Inc.'s Board
     of  Directors  (or  persons  performing  the  equivalent  functions):

     a)   all  significant deficiencies and material weaknesses in the design or
          operation  of  internal  control  over  financial  reporting which are
          reasonably  likely  to  adversely  affect  Endovasc, Inc.'s ability to
          record,  process,  summarize  and  report  financial  information; and


<PAGE>
     b)   any  fraud, whether or not material, that involves management or other
          employees  who  have  a  significant role in Endovasc, Inc.'s internal
          control  over  financial  reporting.

Date: October 13, 2004                       /s/ M. Dwight Cantrell
                                             ------------------------
                                             M. Dwight Cantrell,
                                             Chief Financial Officer


<PAGE>